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Abstract
Background: The proto-oncogene, c-Abl encodes a ubiquitously expressed tyrosine kinase that critically governs
the cell death response induced by genotoxic agents such as ionizing radiation and cisplatin. The catalytic function
of Abl, which is essential for executing DNA damage response (DDR), is normally tightly regulated but upregulated
several folds upon IR exposure due to ATM-mediated phosphorylation on S465. However, the mechanism/s leading
to activation of Abl’s apoptotic activity is currently unknown.
Results: We investigated the role of acetyl modification in regulating apoptotic activity of Abl and the results
showed that DNA strand break-inducing agents, ionizing radiation and bleomycin induced Abl acetylation. Using
mass spectrophotometry and site-specific acetyl antibody, we identified Abl K921, located in the DNA binding
domain, and conforming to one of the lysine residue in the consensus acetylation motif (KXXK–X3-5–SGS) is
acetylated following DNA damage. We further observed that the S465 phosphorylated Abl is acetyl modified
during DNA damage. Signifying the modification, cells expressing the non acetylatable K921R mutant displayed
attenuated apoptosis compared to wild-type in response to IR or bleomycin treatment. WT-Abl induced apoptosis
irrespective of new protein synthesis. Furthermore, upon g-irradiation K921R-Abl displayed reduced chromatin
binding compared to wild type. Finally, loss of Abl K921 acetylation in Tip60-knocked down cells and co-
precipitation of Abl with Tip60 in DNA damaged cells identified Tip60 as an Abl acetylase.
Conclusion: Collective data showed that DNA damage-induced K921 Abl acetylation, mediated by Tip60,
stimulates transcriptional-independent apoptotic activity and chromatin-associative property thereby defining a
new regulatory mechanism governing Abl’s DDR function.
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Background
DNA damage response is a highly conserved response
elicited by genome damaging agents that ultimately
serves to protect genome integrity by inducing cell cycle
arrest, DNA repair, or apoptosis [1,2]. Recent studies
showed that covalent modification by acetylation, in
addition to phosphorylation, regulates the activity of a
number of proteins mediating the DDR [3-5]. Principal
acetyl-transferases (ATs), implicated in DDR include
p300, CREB-binding Protein (CBP), pCAF and the
MYST family acetylases,Tip60 (KAT5) and hMOF [5-9].
Consistent with their role in DDR, cells compromised
for p300, Tip60 or hMOF function exhibit heightened
sensitivity to DNA damaging agents due to defective
cell-cycle checkpoint activation, DNA repair and or
apoptosis [4,5]. Substrates of DNA damage-responsive
acetyl-transferases include both histones and non-his-
tone proteins such as p53, p73a, Ku70, E2-F1 and Sp1
[10-15]. In general, modification of histones by acetyla-
tion leads to unfolding of the nucleosomal fiber struc-
ture at DNA strand breaks perhaps facilitating access to
DNA damage signaling and repair proteins [3,4]. On the
other hand, acetylation of non-histone proteins is shown
to stimulate their DNA-binding and transactivation
function. In the case of p53, acetylation is shown to sti-
mulate DNA-binding, stability and pro-apoptotic activity
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[10-12]. Similarly, acetylation of Ku70, E2F-1 and p73a
selectively stimulates their apoptotic gene-specific trans-
activation function [13-15]. Interestingly, acetylation of
Sp1 is shown to loosen bak promoter DNA binding
[16]. Acetylation of ATM kinase, mediated by Tip60
complexed with MRE11-RAD50-NBS is shown to stimu-
late ATM’s catalytic function during DNA damage [17].
Loss of acetylation due to depletion of hMOF by RNA
interference prevents ATM-mediated phosphorylation of
p53 and Chk2 [18]. Altogether, available evidences sug-
gest that acetylation is an important modification that
critically governs the activity of DDR proteins.
The ubiquitously expressed Src-related c-Abl tyrosine
kinase is a well-documented regulator of cellular responses
induced by oxidative stress, DNA damaging agents and
growth factors [19-22]. Abl null mice display lymhopenia,
reduced fertility, osteoporosis, and high neonatal mortality
indicating its importance in normal growth and develop-
ment [23]. Abl contains a large C-terminus whose deletion
also caused neonatal lethality in mice signifying the biolo-
gical role of this domain [24]. In this C-terminus, several
discrete functional domains such as DNA binding domain
(DBD), nuclear location and export sequences (NLS, NES)
and RNA polymerase II-C-terminal binding domain
(CTD) have been identified [25-28]. The presence of both
NLS and NES is thought to allow nuclear-cytoplasmic
shuttling of Abl and gain access to substrates in both com-
partments during signaling. The DBD of Abl is hyperpho-
sphorylated by cdc2 during mitosis and this correlates
with decreased chromatin association [26]. In vitro studies
showed that Abl binds A/T-rich sequences through
HMG-1 like boxes (HLBs) located within its DBD [27].
The RNAP II CTD is required for processive phosphoryla-
tion of Pol II largest subunit and for transcription
enhancement function of Abl [28]. The catalytic function
of Abl is normally tightly regulated through inter/intra-
molecular association [20-22] and phosphorylation [29]
but stimulated upon exposure to IR or other genotoxic
agents (e.g. cisplatin, methyl methane sulfonate, mitomy-
cin C and hydrogen peroxide) [19,20]. Gamma-radiation
induced Abl kinase activation is due to S465 phosphoryla-
tion mediated by ATM kinase [29]. Kinase-activated Abl,
in turn, stimulates the transactivation property of p53 and
its family members, p73a and p63a either through direct
phosphorylation and/or association [30-33]. Corroborating
well with attenuated induction or activation of Abl down-
stream targets, Abl-/- mouse cells display apoptotic-resis-
tant phenotype against a class of genotoxins [21,22].
Phosphorylation of a subset of DNA repair proteins,
DNA-PK and RAD9 by Abl is shown to diminish their
repair capability [34-36], although phosphorylation of
RAD51 enhanced its association with RAD52 and conse-
quently repair [37]. In sum, current data suggests that Abl
modulates the cell death response induced by DNA dama-
ging agents through multiple mechanisms involving acti-
vation of pro-apoptotic molecules and inactivation of
DNA repair proteins.
We investigated whether acetyl modification is stimula-
tory for Abl’s apoptotic function and observed that induc-
tion of DSB, either through IR exposure or treatment with
belomycin, triggers c-Abl acetylation on K921. The
requirement of S465 phosphorylation for K921 Abl acety-
lation further revealed that ATM-activated Abl is a sub-
strate for DNA damage responsive acetyl-transferase/s.
Attenuated apoptosis induced by DSB generating agents
in cells expressing K921R mutant irrespective of new pro-
tein synthesis demonstrated the modification requirement
in stimulating non-transcriptional apoptosis induced by
Abl. Reduced chromatin binding displayed by K921R-
Abl mutant compared to wild type Abl in IR exposed
cells showed that acetylation positively modulates the
DBD activity of Abl and may be closely linked to its non-
transcriptional apoptotic activity. Finally, the ability of
Tip60 to interact with Abl both in vitro and in vivo identi-
fied Tip60 as an upstream Abl modifier in the DNA
damage signaling pathway.
Results
IR exposure induces acetylation of c-Abl
To determine whether Abl is acetylated post DNA
damage, extracts of HeLa cells exposed to either IR (5
Gy) or UV (20 J/m2) were formed at 0, 2 and 4 h post-
treatment and Abl was immunoprecipitated using anti-
Abl (K12) antibody. Western blot analysis of the precipi-
tants with pan-specific anti-acetyl lysine antibody
revealed an immunoreactive band of ~130 kDa corre-
sponding to the size of Abl in IR exposed samples (Fig-
ure 1a; lanes 2 and 3, top panel). Neither untreated nor
UV-treated extracts displayed this immune-reactive
band despite comparable presence of Abl protein (bot-
tom panel). A similar analysis using Abl-/- 3T3 cells
reconstituted with Flag-tagged Abl confirmed that the
acetyl modification is induced specifically by IR but not
UV (Figure 1b). We next radiolabeled Flag-Abl+ 3T3
cells with [14C] acetyl CoA and exposed to IR. Resolu-
tion of Abl immune-complex by SDS-PAGE followed by
autoradiography showed a 14C-labeled band of ~130
kDa in IR exposed samples that coalesced with Abl
band, revealed by immunoblotting (Figure 1c). Samples
treated with UV did not display this radiolabeled band.
To map the acetylation site, we transfected 293T cells
with cDNA constructs of Abl containing truncations or
internal deletions (Figure 1e), and then assessed for IR-
induced acetyl modification. Wild type, ΔSca and ΔBgl-
Abl showed acetylation whereas the DNA binding
domain (DBD) deleted mutant constructs ΔXho and
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ΔXho-Sal did not display this modification (Figure 1d).
The data showed that the DBD of Abl harbors the
acetyl-modified residue/s.
K921 of Abl is acetylated in response to DNA damage
To identify the acetyl modified residues, 293 cells transi-
ently expressing Flag-tagged Abl were exposed to IR and
Abl was immunopurified, subjected to trypsin digestion,
and analyzed by MS. Database searching using sequest
identified mouse cAbl (P00520) with high confidence
(Additional Files 1 &2). Specific MS/MS analysis of the
peptide ion at m/z 477.8 corresponding to the (M+3H)3+
species showed a mass of 1431 Da, an increase of 56 Da
compared to the calculated mass of peptide without
modification. Acetylation of K921 and methylation of
Cys899 (44Da + 14Da = 56Da) or carbamidomethylyation
of Cys899 could account for the increased mass of the
modified peptide; however, if Cys899 (57 Da mass
Figure 1 IR exposure induces c-Abl acetylation. (a) HeLa cells were exposed to 5 Gy of IR or 20 J/m2 of UV and collected at 0, 2 and 4 h
later. Anti-Abl immunoprecipitates were prepared using K-12 antibody and resolved on a 5-15% SDSPAGE. The proteins were transferred onto
Immobilon-P and immune-analyzed with pan-specific anti-acetyl lysine antibody (top panel). The membrane was stripped as described in
methods and reprobed with anti-Abl antibody (bottom panel). (b) Abl-/- 3T3 cells reconstituted with Flag-tagged Abl were either mock, IR (5 Gy)
or UV (20 J/m2) treated and collected 4 h later. Anti-Abl immunoprecipitates were prepared and immune-analyzed with acetyl lysine (top panel)
or Flag antibody (bottom panel). (c) Abl-/- 3T3 cells reconstituted with Flag-tagged Abl were labeled with 14C acetyl CoA for 2 h and then
exposed to IR (5 Gy) or UV (20 J/m2) and collected 4 h later. Anti-Abl immunoprecipitates were prepared, resolved on 8% SDS-PAGE, and
subjected to fluorography followed by autoradiography (top panel). An aliquot of the immune complex was immune-analyzed with Flag
antibody (bottom panel). (d) 293 cells were transfected with either vector alone or the indicated Abl constructs shown in panel e, using
lipofectamine. At 36 h post-transfection, cells were exposed to 5 Gy of IR and anti-Flag immunoprecipitates were formed and immune-analyzed
with anti-acetyl lysine (top panel) or anti-Flag antibody (bottom panel). (e) Schematic representation of the Abl constructs used in the
experimentation described in panel d.
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change) is carbamidomethylated, the corresponding Y7
+,
Y8
+, and Y9
+ ions in the spectrum would be assigned to
mass peaks that is approximately 1 Da higher in mass.
MS/MS data, therefore, points to the possibility of acety-
lation on K921 with a better match of peaks between
observed and calculated mass.
Located in the DBD (Figure 2a), K921 of Abl repre-
sents one of the two lysine residues within a consensus
acetylation sequence (KAGK–PAQ–SPS) found in HAT
substrates such as E2F-1, p53 and Ku70 [11-14]. As a
logical extension, K921 and K924 of Abl were individu-
ally substituted with arginine (R) and tested for acetyl
modification by IP followed by immunoblotting against
anti-acetyl lysine antibody. K921R mutant was resistant
to IR-induced acetyl modification demonstrated by lack
of reactivity to acetyl-lysine antibody (Figure 2b).
Figure 2 K921 of Abl is modified by acetylation following DNA strand breaks. (a) Structure of c-Abl with the consensus acetylation
sequence (mouse and human) located in the DNA-binding domain (DBD) is shown. (b) Abl-/- 3T3 cells, reconstituted with Flag-tagged WT or
K>R (921, 924) mutants of Abl, were either mock-treated or exposed to 5Gy of IR. Anti-Flag immunoprecipitates were prepared and immune-
analyzed with acetyl-lysine (top panel) or Flag antibody (bottom panel). (c) Immunoblot, shown in panel A, was reprobed against K921 site-
specific acetyl-Abl antibody (top panel). An aliquot of the lysate was also immune-analyzed with anti-Flag antibody (bottom panel). (d) Bleomycin
induces K921 Abl acetylation. Abl-/-3T3 cells reconstituted with vector or Flag-tagged Abl were exposed to bleomycin (10 μM; 1 h) and lysates,
prepared 4 h later, were subjected to immunoblotting with K921 acetyl Abl (top panel) or anti-Flag (bottom panel) antibody.
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However, reactivity to K924-Abl remained comparable
to WT. We next generated K921 site-specific acetyl-Abl
antibody by immunizing rabbits with acetylated Abl
peptide (described in Methods) and evaluated its reactiv-
ity to WT and K>R mutant of Abl by reprobing the
membrane, shown in panel A. Result showed compar-
able reactivity to WT and K924R mutant of IR-treated
cells but least to K921R mutant (Figure 2c). We next
immune-analyzed lysates formed from cells treated with
DSB-inducing agent, bleomycin and observed acetylation
of WT and K924R mutant but not K921R mutant at
both 2 and 4 h post-treatment (Figure 2d). Collective
data established that DSB signals triggers K921 Abl
acetylation.
S465 phospho-Abl is acetylated post DNA damage
ATM-mediated phosphorylation on residue S465 stimu-
lates Abl kinase activity upon IR exposure [29]. To study
the interplay between kinase activation and acetylation,
we tested the effect of Abl kinase inhibitor, imatinib
(gleevec) on IR-induced K921 Abl acetylation. Immune-
analysis of the lysates with K921-Ac-Abl antibody
revealed that the inhibitor blocked K921 Abl acetylation
induced by IR (Figure 3a, compare lane 4 to 2). Reduced
p-Tyr content on Abl in inhibitor-treated cells compared
to control treatment, revealed by anti-p-Tyr (4G10)
immunoblotting confirmed Abl kinase inhibition (bottom
panel, compare lane 4 to 2). A similar result was obtained
with the kinase-inactive Abl mutant (K290R) in that the
mutant showed decreased K921 acetylation compared to
WT after IR treatment (Figure 3b). Examination of Abl
acetylation in ATM-proficient (YZ-5) and deficient (EBS-
7) fibroblasts showed that the modification induced by IR
is dependent on ATM function (Figure 3c, lane 2). To
determine whether ATM phosphorylated Abl is subject
to acetyl modification we next examined modification on
the phosphorylation-resistant S465A and the constitu-
tively active S465E mutant of Abl. Whereas WT and
S465E-Abl mutant displayed K921 Abl acetylation,
S465A mutant showed very little acetylation (Figure 3c,
lanes 2 and 6). S465E mutant displayed acetylation in the
absence of IR that was further enhanced after g-irradia-
tion by ~5.53 fold (Figure 3d, lanes 5 and 6). Taken
together, the results showed that ATM phosphorylated
S465-Abl is acetyl modified on K921 post DNA damage.
Identification of Tip60 as a predominant Abl-specific
acetylase
In an attempt to identify the acetylase responsible for
modifying Abl, we initially examined the requirement of
p300 HAT. However, comparable K921-Abl acetylation in
HCT116/p300- cells containing targeted deletion of exon
2 of EP300 gene [7] and in the parental HCT116 cell line
demonstrated p300 dispensability (Additional File 3). We
next tested the contribution of MYST-family acetyl-trans-
ferases, Tip60 and hMOF by transfecting HeLa cells with
synthetic siRNA specific for either hMOF or Tip60. After
confirming reduction of their expression by immunoblot-
ting (Figure 4a), the transfectants were exposed to 5 Gy of
IR and Abl acetylation was assessed. Result showed
that the modification was partially inhibited in hMOF-
suppressed cells but was completely abrogated in Tip60-
suppressed counter parts (Figure 4a, top panel, compare
lane 4 and 6 to 2). To further evaluate the involvement of
Tip60, we co-expressed Abl with either WT or HAT-
defective mutant of Tip60 (Q377E/G380E) in 293T cells
and immune-analyzed the lysates for K921 Abl acetylation.
WT Tip60 expressing population displayed modest acety-
lation that was greatly enhanced after g-irradiation (Figure
4b, top panel, compare lane 1 to 2). In contrast, cells
expressing Tip60 mutant displayed diminished IR-induced
Abl acetylation (lane 4). Anti-Tip60 (HA) immunoblotting
confirmed comparable WT and Tip60mtexpression in
these transfectants (Figure 4b, bottom panel). To deter-
mine whether Abl is directly acetylated by Tip60 we per-
formed in vitro HAT assays using GST fragments carrying
various domains of Abl as substrates (Figure 4c). Incuba-
tion of Abl fragments with Tip60 immunopurified from g-
irradiation-treated HeLa cells in the presence of 14C-acetyl
CoA resulted in labeling of the GST Xho-Sal fragment
containing the DBD of Abl (Figure 4d, lane 3, top panel),
in agreement with the presence of K921 residue in this
domain. Neither GST-ABC nor GST-SE displayed 14C
labeling. Coomassie blue staining showed comparable sub-
strate in each of these HAT reactions (middle panel).
Similarly, anti-Tip60 immunoblotting confirmed the pre-
sence of equivalent levels of Tip60 in each of the HAT
reactions (bottom panel). Together, the findings demon-
strated that Tip60 acetylates Abl in response to DNA
damage although a role for hMOF cannot be completely
ruled out.
c-Abl co-precipitates with Tip60 acetylase following DSB
induction
To examine whether c-Abl associates with Tip60 in vivo
we performed co-immunoprecipitation assays using
lysates prepared from Flag-Abl and HA-Tip60 trans-
fected 293 cells. Result showed the presence of Abl in
anti-Tip60 (HA) immunoprecipitates prepared from
extracts of IR-but not mock-treated cells (Figure 5a). No
association was observed in UV-treated cell lysates.
When endogenous interactions between Tip60 and Abl
was assessed in reconstituted Abl+3T3 cells we observed
that cells treated with bleomycin (Figure 5b) showed
enhanced association than observed with control treat-
ment. The findings allow us to conclude that DNA
damage enhances association between Abl and Tip60
consequently facilitating acetylation.
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K921 acetylation is required for Transcription-
independent apoptosis mediated by Abl
Given that acetylation activates the pro-apoptotic activ-
ity of E2-F1, p53 and p73a [12-14] we examined
whether acetylation stimulates Abl’s apoptotic function.
For this purpose, cells reconstituted with WT or the
non-acetylatable K921R-Abl mutant were exposed to 10
μΜ of belomycin and cell death was assessed at 48 h
post-treatment. Annexin V/PI staining followed by flow
cytometric analysis revealed ~20.7% apoptosis (early and
late) in cells expressing WT Abl (Figure 6a). Under
similar conditions, % apoptosis in cells expressing
K921R mutant was ~9.6, a number that represents ~2
fold reduction compared to WT. When the results of
three independent experiments were combined, cells
expressing the K921R mutant showed a statistically sig-
nificant (*P < 0.01) reduced apoptosis compared to WT
(Figure 6b) consistent with acetylation as a required
Figure 3 ATM phosphorylated Abl is targeted for acetyl-modification on K921. (a) HeLa cells were incubated with STI571 (10 μM; 1h) and
then either mock treated or exposed to 5 Gy of IR. At 4 h post-treatment, lysates were prepared, adjusted for equal protein content and
immune-analyzed with K921 Ac-Abl antibody (top panel) or K-12 Abl antibody (middle panel). Anti-Abl immunoprecipitates were also prepared
and probed with anti-pTyr antibody (bottom panel). (b) IR-induced acetylation of WT and Kinase-defective Abl mutant. Abl-null 3T3s reconstituted
with WT or kinase-defective Abl (K290R) were exposed to IR (5 Gy) and lysates were formed and subjected to immunoblot analysis with K921
Ac-Abl antibody. (c) Mock- and IR-treated ATM-deficient(EBS-7) and ATM-proficient (YZ-5) fibroblasts were collected at 4 h post-treatment and
lysates were formed, adjusted for equal protein concentration, and subjected to immunoblotting with K921 Ac Abl (top) or anti-Abl (bottom)
antibody. (d) 293T cells were transfected with WT, S465A or S465E mutant of Abl cDNA. At 36 h post-transfection, cells were exposed to IR (5
Gy) and lysates were formed 4 h later and subjected to immunoblotting with K921 Ac Abl (top panel) or anti-Flag (middle panel) or anti-pTyr
(4G10) antibody (bottom panel). (e) Fold increase in acetylation was assessed by densitometric analysis of the immune-reactive band using
phosphor-imager and the data are presented as means ± SD, n = 3.
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modification for activating Abl’s cell death-inducing
ability. To determine whether K921 acetylation pro-
motes transcription-dependent or independent apopto-
sis, we included the de novo protein translation
inhibitor, cyclohexamide in the assay. Although the inhi-
bitor was slightly toxic demonstrated by high basal levels
of cell death inWT and K921R mutant (~7.8% and
~8.2%, respectively) it neither affected Abl expression
nor K921 acetylation (Additional File 4). Nonetheless,
when bleomycin-induced cell death was assessed in the
presence of CHX, % cell death in WT-Abl cells was
slightly reduced (~15.3%) compared to that observed in
the absence (~20.7%). K921R mutant showed signifi-
cantly reduced cell death both in the absence or absence
of the inhibitor (~7.8% vs ~9.6%). Attenuated apoptosis
displayed by the K921R mutant irrespective of new pro-
tein synthesis demonstrated a requirement for Abl acet-
ylation in triggering transcription-independent cell
death. Correlating well these results, immunoblot analy-
sis of the lysates prepared from these panel of cells with
anti-PARP and anti-caspase-3 antibody (that recognizes
cleaved fragment) showed comparable cleavage in
bleomcyin-treated WT Abl cells in the presence or
absence of CHX (Figure 6c, compare lane 2 and 4).
Lysates of K921R mutant cells showed reduced but
comparable cleavage irrespective of inhibitor treatment,
consistent with attenuated cell death (compare lane 6
to 7).
To reinforce the results of the above analysis, HeLa cells
stable depleted for Abl expression by shRNA (described in
our previous publication Ref: 44) were transfected with
WT or K921R mutant of Abl, along with transfection mar-
ker, GFP. At 36 h post-transfection, cells were exposed to
4.3 Gy of IR, a dose that triggers optimal cell death in these
cell lines, and cell death was assessed by flow cytometric
analysis of cells gated for GFP+ population (Figure 7a
Figure 4 K921 Abl acetylation is mediated by Tip60 acetyl-transferase. (a) Human colorectal cancer cells (HCT116+Ch3;H3) were transfected
with siRNA specific for Luciferase, Tip60 or hMOF and then mock treated or exposed to IR (5 Gy) at 36 h post-transfection. Lysates were formed
at 4 post-treatment, normalized for equal protein content, and immune-analyzed with K921 Ac Abl or Abl antibody. An aliquot of the lysate was
also subjected to immunoblotting with anti-Tip60 or hMOF antibody. (b) 293T cells were transfected with plasmids carrying WT or HAT-defective
Tip60mt cDNA, and at 36 h post-transfection, cells were mock-treated or exposed to 5 Gy of IR. Lysates were formed 4 h later and subjected to
immunoblotting with K921 Ac Abl (top panel), anti-Flag (middle panel) and anti-Tip60 antibodies, respectively (bottom panel). (c) Structural
domains of GST-Abl fusion products (Abl-ABC, Abl-XS and Abl-SE). (d)Tip60 acetylates c-Abl in vitro. GST-fusion proteins, shown in panel C, were
expressed in bacteria purified, and incubated with Tip60 immunoprecipitates prepared from IR (5 Gy)-treated HeLa cells in the presence of 14C-
acetyl CoA in HAT buffer. The reaction products were resolved in 5-15% SDS-PAGE and the gel was dried and exposed to autoradiography (top
panel). Coomassie blue staining of the GST-fusion products (middle panel). Anti-Tip60 immunoblotting (bottom panel).
Jiang et al. Molecular Cancer 2011, 10:88
http://www.molecular-cancer.com/content/10/1/88
Page 7 of 15
and 7b). Determination of % sub-G1 DNA containing
population revealed reduced cell death in K>R mutant
(~6.2%) compared to WT-Abl expressing cells (~14.6%).
When cell death was assessed in the presence transcription
inhibitor, a-amanitin, a RNA polymerase II poison, we
observed slightly reduced cell death in WT-Abl cells
(~11.6%) compared to control treatment (~14.6%). How-
ever, K921R mutant showed similar levels of cell death
both in the presence and absence of the inhibitor (~6.2%
vs ~5.3%). Consistent with these results, comparably
diminished PARP and caspase-3 cleavage was observed in
lysates formed from K921R expressing cells with or with-
out a-amanitin (Figure 7c). Taken together, the findings
reinforced the involvement of Abl, and more importantly,
K921 Abl acetylation requirement in promoting transcrip-
tion-independent apoptosis triggered by DSB-inducing
agents.
K921 acetyl-Abl is enriched in chromatin fraction of IR-
treated cells
Abl association with chromatin is negatively regulated
during mitosis by cdc2-mediated phosphorylation on
multiple ser/thr residues, located in the DBD of Abl
[26]. To determine whether Abl acetylation on K921
affects its chromatin-associative property, we compared
the presence of acetyl-Abl in chromatin fractions of
mock and IR exposed cells. Extracts formed from mock-
and IR-treated Abl+ 3T3 cells were separated into
nuclear and cytoplasmic fractions as described in Meth-
ods and their integrity was confirmed by immunoblot-
ting with chromatin marker, Orc2 and cytoplasmic
marker, tubulin (Figure 8a). Nuclear fractions were then
divided into equal aliquots and immunoprecipitated
with either K921 Ac-Abl or Abl antibody. Anti-Abl
immunoblotting showed increased presence of both
acetyl-Abl and total Abl in chromatin fractions of IR-
treated extracts compared to mock-treated samples (top
panel, compare lane 2 to 1). Cytoplasmic fractions
showed no alterations in Abl content between mock-
and IR-treated cells (bottom panels, lanes 5 and 6).
K921R-Abl mutant showed a lack of enrichment in the
chromatin fraction following irradiation (Figure 8b).
Levels of K921R Abl in the unbound fractions of mock-
and IR-treated cells remained unchanged. The impaired
chromatin association displayed by the K921R mutant
compared to WT in IR-treated cells suggests that acetyl
A
B
IR (5 Gy) - +      - +
VectorAbl
1       2         3     4
Tip60 (HA)
Abl (Flag)
293
0       2     4     0      2     4
Blm (10 PM)
Tip60
Abl (K-12)
K921 Ac-Abl
U2OS  
1      2      3        4       5       6   
UV (20 J/ m2)
Figure 5 Co-precipitation of Abl with Tip60 following DSB induction. (a) 293 cells were transfected with pcDNA3.2 plasmids carrying Flag-
Abl and HA-Tip60 cDNA using lipofectamine. At 36 h post-transfection, cells were exposed to 5 Gy of IR 4 h later lysates were formed, adjusted
for equal protein content and subjected to immunoprecipitation with anti-HA antibody. Immunoprecipitates were resolved on SDS-PAGE and
subjected to western blotting against anti-Flag (top panel) or anti-HA antibody (bottom panel). (b) Abl-null 3T3 cells reconstituted with vector
alone or Flag-tagged WT-Abl were exposed to bleomycin (10 μM) and collected 0, 2 and 4 h later. Lysates were formed, adjusted for equal
protein concentration and subjected to immunoprecipitation with anti-Flag (Abl) antibody. The immune-complexes were resolved on SDS-PAGE,
transferred onto Immobilon-P and probed with anti-HA (Tip60) or anti-Flag (Abl) antibody.
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modification positively modulates Abl’s chromatin-bind-
ing activity and may be closely linked to its non-tran-
scriptional apoptotic activity.
Discussion
Induction of apoptosis is a central function of c-Abl in the
DNA damage signaling pathway; however, the mechan-
ism/s leading to activation of its apoptotic activity is not
known. While previous studies established that the kinase
function of Abl is essential for its cell death-inducing func-
tion [20-22] and is activated by phosphorylation, the pre-
sent study demonstrates that acetylation activates Abl’s
apoptotic activity. Specifically, our study shows that K921
of Abl, located within the DNA binding domain, and con-
fining to one of the lysine in the consensus acetylation
motif identified in pro-apoptotic molecules such p53, E2F-
1 and p73a [12-15] is modified by acetylation during
DNA damage. Acetylation selectively activates the non-
transcriptional cell death induced by Abl as the non-
acetylatable K921R mutant displayed attenuated apoptosis
compared to WT in the absence of new protein synthesis.
Decreased chromatin binding displayed by the acetyl-resis-
tant K>R mutant compared to wild-type supports the
argument that acetyl modification positively modulates
chromatin-binding property of Abl and may be closely
linked to its apoptotic activity. Finally, our observation
that Tip60 associates with and acetylates Abl both in vitro
and in vivo identified Tip60 as a predominant DNA
damage responsive acetylase that modifies Abl on K921.
Results of the present study raise an interesting question
about how DNA damage induces K921 acetylation and
activates its apoptotic activity. Acetylation of pro-apoptotic
molecules such as p53 and p73a activates selective trans-
activation function towards apoptotic genes, bax and
puma through enhanced promoter DNA binding [11,15].
On the other hand, acetylation of Sp1 is shown to loosen
binding to bak promoter consequently allowing access of
Sp3 to the promoter region to drive bak transcription [16].
Figure 6 Acetylation of Abl on K921 is required for transcription-independent apoptosis triggered by DNA strand breaks. (a) Abl+ 3T3
cells expressing WT or K921R Abl mutant were pre-treated with 100 μg/ml of CHX or vehicle for 1 h and then exposed to 10 μΜ bleomycin
(Blm) for 1 h. Cells were collected 48 h later, stained with Annexin V/PI and analyzed by flow cytometry. (b) Percent AnnexinV/PI-positive and
cell population shown in panel A is graphed. Mean value obtained from three independent experiments with SD is given. *P < 0.01; **P < 0.05.
(c) Lysates of mock and Blm-treated cells (10 μM; 1 h), shown in panel A, were adjusted for equal protein content and immunoblotted against
PARP (top panel), caspase-3 (middle panel) or tubulin antibody (bottom panel).
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However, unlike p53, p73a and Sp1, c-Abl is not known
to bind specific DNA sequence. Instead, in vitro DNA
binding studies showed that Abl binds A/T rich DNA
sequences through its HMG-1 like boxes (HLBs), located
within its DBD [27]. David and coworkers [38] further
reported that Abl binds DNA sequences containing AAC
motifs and to distorted DNA structures. HMG proteins
such as HMG1A and HMGI/Y are shown to bind A/T-
rich stretches of chromatin through AT-hooks and contri-
bute to chromatin remodeling [39-41]. Moreover, HMG
proteins have been reported to displace DNA repair mole-
cules from chromatin allowing the access of DNA caspases
and nucleases [40-42]. Phosphorylation of a subset of
DNA repair proteins, Rad9 and DNAPK by Abl is docu-
mented to suppress their repair capability [34,36]. When
taken together, the findings lead us to speculate that acety-
lated Abl induces transcription-independent apoptosis
through binding to AT/AAC rich sequences in chromatin
facilitating remodeling and or inhibiting DNA repair.
Another intriguing possibility is that Abl may promote
apoptosis through increased Bad/Bax protein accumula-
tion. In the cytoplasm, pro-apoptotic proteins such as Bax
and Bad are kept inactive through interactions with 14-3-3
proteins. Yoshida et al [43] showed that JNK-mediated
phosphorylation of 14-3-3 dissociates 14-3-3/c-Abl com-
plex consequently leading to increased nuclear accumula-
tion of c-Abl. Conceivably, nuclear retention of acetyl
modified Abl through chromatin association may lead to
reduced availability of Abl in the cytoplasm consequently
allowing accumulation of Bad and Bax in the cytoplasm
Mock
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1       2       3      4        5     6      7     8
IR (5 Gy) - +      - +      - +    - +
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caspase-3
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Figure 7 Restoration of WT but not K921R mutant of Abl reinstates IR-induced transcriptional-independent apoptosis. (a) HeLa cells
stable depleted for Abl expression were transfected with either WT or K921R-Abl mutant along with GFP cDNA constructs. 36 h post-
transfection, cells were incubated with 100 μg/ml of a-amanitin or vehicle for 2 h and then either mock-treated or exposed to 4.3 Gy of IR. 48 h
later, cells were then stained with PI and subjected to flow cytometry. (b) Percent sub-G1 DNA containing GFP+ cell population is graphed and
mean value obtained from three independent experiments with SD is given. *P < 0.01; **P < 0.01. (c) Lysates of mock and BLM-treated cells
were adjusted for equal protein content and subjected toimmunoblotting with anti-PARP (top panel) or anti-caspase-3 antibody (middle panel).
Anti-tubulin immunoblotting shows equal protein loading (bottom panel).
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and enhancing cell death. Additional studies, however, are
required to fully uncover the precise mechanism by which
Abl promotes transcriptional-independent apoptosis.
The mechanism by which DNA damage induces Abl
acetylation by Tip60, at present, remains speculative.
The lack of acetyl modification on DNA binding domain
deleted mutants of Abl (ΔXho-Sal and ΔXho) indicates
a requirement and an involvement of this domain for
the modification. In addition, Abl requires ATM phos-
phorylation and residue (S465) for the modification
since the phosphorylation resistant mutant, S465A-Abl
failed to undergo acetylation upon exposure to IR and
bleomycin. Moreover, the kinase-defective K290R-Abl
was resistant to acetylation triggered by these DSB-indu-
cing agents. We speculate that Abl either binds DNA
lesion directly through its DBD or recruited to the
lesion as part of ATM complex for interaction and acet-
ylation by Tip60.Acetylation does not influence Abl
kinase activity since activation was observed within 1 h
post IR and acetylation was observed 2 h later. More-
over, mutants of Abl that cannot be activated (S465A-
Abl and K290R-Abl) are resistant to acetylation induced
by IR. The constitutively active S465E-Abl mutant, on
the other hand, displayed K921 acetylation that was
further enhanced after irradiation. These observations
suggest that acetylation is a secondary modification that
occurs on kinase-activated Abl.
Although Tip60 is essential for K921 Abl acetylation,
the current study does not preclude hMOF acetylase in
mediating the modification since hMOF-suppressed
cells showed partially abrogated acetylation. Cross-talk
between Tip60 and human MOF has been reported [9].
Moreover, hMOF has been reported to influence ATM
activation in response to DNA damage as depletion of
hMOF prevents ATM-mediated phosphorylation of p53
and Chk2 [18]. Such findings impart a role of hMOF in
Figure 8 Enrichment of K921 Acetylated Abl in chromatin fractions of g-irradiated cells. (a) Reconstituted Abl+ 3T3 cells were exposed to
IR (5 Gy) and at 18 h post-treatment, cells were harvested, lysed in hypotonic buffer and fractionated into nuclear and cytoplasmic fraction as
described by Méndez et al [46]. Nuclear fraction was again separated into chromatin bound and unbound and subjected to
immunoprecipitation with anti-Abl (K-12) antibody. The immune-complex was analyzed by subjecting to western blotting with K921 Ac-Abl or
Abl antibody (top panels). Input lysates were also blotted with tubulin (cytoplasmic marker) or ORC2 (chromatin marker) antibody (bottom panel).
(b) Abl-/- 3T3 cells reconstituted with K921R mutant of Abl were exposed to 5 Gy of IR and nuclear and cytoplasmic fractions were formed and
immune-analyzed for K921 Ac-Abl, Abl, tubulin or ORC2 proteins as described in panel a.
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acetylating Abl in response to DNA damage, in addition
to Tip60. It is interesting to note that pro-apoptotic pro-
teins such as p53 and E2F-1 are initially modified by
phosphorylation, and at latter time-point, by acetylation.
Whereas phosphorylation of p53 leads to stabilization,
enhancement of promoter DNA binding and activation
of its cell-cycle arrest function, acetylation is shown to
positively modulate its apoptotic activity. Clearly, a par-
allel can be drawn between Abl and these DDR proteins
in terms of regulation of their activity by coupled pro-
cess of phosphorylation/acetylation. Specifically, when
taken with the previous findings that observation that
Abl contributes to growth arrest response [45], and is
activated by ATM-mediated phosphorylation upon irra-
diation [29] lead us to speculate that combined modifi-
cation by phosphorylation and acetylation modulates the
cell growth and apoptotic activity of Abl following DNA
damage.
Significance of the current study can be realized from
the critical role that Abl plays in mediating the apoptotic
response to chemotherapeutic agents that inflict genome
damage [20-22]. A recent study showed that activated
endogenous Abl kinase dramatically promotes breast can-
cer cell proliferation and anchorage-independent growth
in serum, as well as survival following nutrient deprivation
[46]. Additionally, as a co-activator of Androgen receptor
(AR), Tip60 contributes to the progression of chemothera-
peutic-resistant prostate cancer cell proliferation [47].
Given these observations, the identification of Abl as a
Tip60 substrate may be a useful therapeutic tool for devel-
oping novel therapeutics in the treatment of cancer.
Conclusion
In summary, our results reveal a new regulatory mechan-
ism controlling the apoptotic activity of Abl kinase dur-
ing DNA damage. Specifically, our data shows that K921
Abl acetylation, mediated by Tip60, is a relevant post-
translational modification that stimulates the transcrip-
tion-independent apoptosis induced by DSB. The positive
influence exerted by acetylation on chromatin binding
function of Abl suggests a link to promoting its apoptotic
activity independent of transcription.
Methods
Cells
293T and HeLa cells were obtained from ATCC and
cultured in DMEM containing 15% heat-inactivated fetal
bovine serum and 5% penicillin/streptomycin. Cells were
grown in a 5% CO2 incubator at 37°C. EBS-7 and YZ-5
cells were cultured as described [29]. HCT116+ch3 (H3)
cells were cultured as described [44]. HCT116/p300-
and the parental HCT116 cell line, a generous gift from
Dr. Caldas (Johns Hopkins, Baltimore), were grown and
maintained as described [7].
Antibodies
Anti-Tip60 (07-038) and anti-p-Tyr (4G10) antibodies
were obtained from Millipore, MA. Pan-specific acetyl-
lysine (C4; sc-8663), monoclonal anti-p53 (D01; sc-126),
anti-p300 (sc-585) and tubulin antibodies were obtained
from Santa Cruz Biotech Company. HRP-conjugated
secondary antibodies were purchased from Novus Biolo-
gicals (Littleton, CO).K921 site-specific acetyl Abl anti-
body was generated through commercial contract with
Open Biosystems, Inc (Thermo Scientific). In brief, rab-
bits (2) were immunized with the acetylated c-Abl pep-
tide (LKPAPPPPPACTGKacAG) and anti-sera from the
immunized rabbits were subjected to affinity purification
using the acetylated peptide column.
SiRNA-mediated ablation of Tip60 and hMof
Synthetic siRNAs specific for Tip60 5’AAAUCU-
CAUUGCCUGGAGGAUGUCG3’ (sense);5AUAGUACA-
GUGUCUUAUGGUCAAGG-3’ (sense) and (hMOF-1,
GUGAUCCAGUCUCGAGUGA; hMOF-2, AAAGAC-
CAUAAGAUUUAUU; hMOF-3 CAAGAUCACUCG-
CAACCAA; hMSL3-1, CGGUUAGUGAAACUUCCAU;
hMSL3-2, AAAGGUGACUUCGUCUAAA; control,
CACGTACGCGGAATACTTCG, sense strand)were pur-
chased from MWG Biotech. The human colorectal cancer
cell line, HCT116+Ch3 (H3) was transfected with siRNA
using Lipofectamine 2000 (Invitrogen) according to manu-
facturer’s protocol and inhibition of protein expression
was confirmed by immunoblotting.
Construction of c-Abl mutants and Site-directed
mutagenesis
Construction of murine c-Abl (type IV) internal and
truncated mutants was described in a previous study
[28]. Site-specific Abl mutations (K921R, K924R) were
created using PCR-based Quickchange kit from Strata-
gene. The oligonucleotides and its complementary
reverse oligo used as primers for K921R is 5’g cctcctcctgc
ctgcacagggcgcgcaggcaagcccgca cag agc3’/5’ gctctgtgcgggc
ttgcctgcgcg ccc tgtgcaggcaggaggagg c 3’. For K924R muta-
genesis: 5’ cctgcctgcacaggaaaagcagggcgccccgca cag agc ccc
agccaa g 3’/5’ c ttggctggggctctgtgcggggcg ccc tgcttttcctgtgca
ggcagg3’. PCR was carried out using primers (0.1 μmol/L)
of primers, 2.5 units Taq DNA polymerase, and 3 to 15
ng plasmid DNA. The 1.9-kb BssH1-Kas1 fragments con-
taining the desired mutations were subcloned into
pCDNA 3.1 minus vector containing full-length WT Abl
cDNA. All constructs were verified by direct DNA
sequencing.
Immunoprecipitation and Immunoblotting
Cells were exposed to either IR (5 Gy), bleomycin (10 μM)
or UV (20 J/m2) and harvested at the indicated time
points. Cells were washed twice with ice-cold PBS and
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lysed in 1× lysis buffer containing 10 mM Tris-HCl, pH 8,
240 μΜ NaCl, 5 μΜ EDTA, 1 μΜ dithiothreitol (DTT),
0.1 μg/ml of PMSF, 1% Triton X-100, 1 μΜ sodium vana-
date and 1 μM leupeptin, pepstatin, aprotinin by incuba-
tion at 4°C for 20 min. Lysates were cleared by
centrifugation and the supernatants were normalized for
equal protein concentration using BioRad protein assay as
per manufacturer’s instructions. Lysates were resolved on
a 5-12% gradient SDS-PAGE, transferred onto Immobi-
lon-P (Millipore) membrane and probed with the indi-
cated antibody. Equal protein loading was confirmed by
anti-tubulin immunoblotting. For reprobing, the mem-
brane was incubated in stripping buffer containing 65 μΜ
of b mercaptoethanol, 2% SDS, 50 μΜTris-HCl [pH 6.7]
at 55°C for 30 min and then used for immunoblotting
after blocking.
Mass spectrometry
293 cells transfected with Flag-tagged Abl (mouse
Type1V) cells were exposed to 5 Gy of IR and harvested
4 h later. Cells were lysed in 1× lysis buffer (described
above) and incubated with the anti-Flag monoclonal anti-
body-conjugated M2 agarose beads (Sigma). The bound
material was resolved on a 5-15% SDS-PAGE and the Abl
band corresponding to ~130 kDa was excised, incubated
with trypsin, and the products were run through a
Thermo Finnigan LCQ DECA XP Plus ion trap mass spec-
trometer interfaced with a Shimadzu Binary HPLC to
carry out liquid chromatography-tandem mass spectrome-
try (LC-MS/MS) analysis.
HAT Assays
Anti-Tip60 immune-complexes were obtained by incubat-
ing lysates formed from mock and irradiated HeLa cells
with 5 ul of the antibody as described above. The immune-
complex was washed twice in HAT assay buffer (50 μΜ
Tris, pH 8.0/10% glycerol/0.1 μΜ EDTA/1 μΜ DTT) and
incubated with GST-Abl fusion proteins (0.5 μg) in the
presence of 0.5 μCi [acetyl-1-14C] (370 kBq) and cold
Acetyl CoA (10 μM). The reaction was carried out in 60 μl
of HAT buffer for 30 min at 30°C and terminated using 3×
SDS sample buffer. Reaction mixture was resolved on a
5-15% SDS-PAGE, transferred onto Immobilon-P and
exposed to autoradiography after flurography.
Chromatin Fractionation
Chromatin fractionation was performed as described by
Mendez and Stillman [48] with minor modifications.
Approximately 1 × 106 cells were transfected with either
Flag-tagged WT or K>R mutant of Abl using 3T3 Trans-
fection reagent from Mirus, WI. At 36 h post-IR, cells
were exposed to 5 Gy of IR and collected 4 h post-treat-
ment. Cells were washed with PBS and resuspended in
200 μL of Buffer A containing 10 μΜ Hepes, 10 μΜ KCl,
1.5 μΜ MgCl2, 0.34 M sucrose, 10% glycerol, 1 μΜ NaF,
1 μΜ Na2VO3, 0.1%Triton X-100, and protease inhibi-
tors. Cells were incubated on ice for 5 minutes, and cyto-
plasmic proteins were separated from nuclei by
low-speed centrifugation at 1,200 ×g for 5 minutes.
Nuclei were washed with Buffer A and lysed in 200 μL of
Buffer B containing 3 μΜ EDTA, 0.2 μΜ EGTA, 1 μΜ
DTT, and protease inhibitors followed by incubation on
ice for 10 minutes. The lysate was centrifuged at 1,700 ×
g for 4 min. to separate soluble nuclear proteins from
chromatin. The isolated chromatin was washed with Buf-
fer B and pelleted by centrifugation at 10,000 ×g for 1
minute. Chromatin was resuspended in SDS-sample buf-
fer and sheared by sonication and resolved on 5-15%
SDS-PAGE. The proteins were transferred onto Immobi-
lon-P and western blotted against the indicated antibody.
Apoptosis Assays
For quantitation of apoptosis, cells were stained with
Annexin V-FITC2 (Phamingen) and analyzed by FACS
Calibur flow cytometer. Approximately, 10,000 total
events were collected and then subsequently analyzed
for the percentage of Annexin v-FITC (FLH1-H)-posi-
tive, propidium iodide (FL2-H)-negative cells.
Statistical Analysis
Data are expressed as means ± SD and obtained by
combining data from separate experiments. Differences
between control and treated groups were analyzed using
t test (two-tailed, unpaired). Differences with a P value
of <0.05 were considered statistically significant.
Additional material
Additional file 1: MS analysis of trypsin digested products of Abl. A.
Flag-Abl immunopurified from lysates of IR (5Gy) exposed cells were
subjected to in gel digestion following resolution by SDS-PAGE. The
trypsin digested products were subjected to MS analysis on an LCQ Deca
XP Plus.
Additional file 2: MS/MS of the peptide ion at m/z 477.8,
corresponding to the (M+3H)3+ species is shown.
Additional file 3: p300 acetyl-transferase is dispensable for IR-
induced K921 Abl acetylation. Mock-treated and IR (5 Gy) exposed
HCT116 and HCT116/p300-/-cells were harvested 4 h later. Lysates were
adjusted for equal protein content and probed with K921 site specific
anti-acetyl-Abl (top panel), anti-Abl (middle panel) or anti-p300 antibody
(bottom panel).
Additional file 4: Effect of CHX and a-amaninitin on IR-induced Abl
acetylation. Abl+ 3T3 cells were exposed to IR (4.3Gy) in the presence or
absence of CHX or a-amanitin and harvested at the indicated time
points. Lysates were probed with K921 site specific acetyl-Abl (top panel)
or Abl (Flag) antibody (bottom panel).
Abbreviations
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Jiang et al. Molecular Cancer 2011, 10:88
http://www.molecular-cancer.com/content/10/1/88
Page 13 of 15
Acknowledgements
The authors thank Dr. Chinnadurai at University of Texas, Dallas, TX for Tip60
cDNA and Dr. Caldas (Johns Hopkins, Baltimore) for HCT116 and
HCT116/p300-/- cells. The authors thank Dr. Guy Uechi at Genomics and
Proteomics Core Lab (GPCL) at University of Pittsburgh for assistance with
MS analysis. This work was supported by a grant from NIH (RO1GM60945) to
RB and (R01CA123232) to TKP.
Author details
1Department of Microbiology and Molecular Genetics (Z.J., R.V., R.B),
University Drive Pittsburgh, PA 15240, Pittsburgh PA 15261, USA. 2Veterans
Affairs Health Care, University Drive Pittsburgh, PA 15240, Pittsburgh PA
15261, USA. 3Pittsburgh Cancer Institute, Pittsburgh, PA 15261, USA.
4Department of Radiation Oncology, UT SouthWestern Medical Center,
Dallas, TX 75390, USA. 5Genomics and Proteomics Core Laboratories, 3343
Forbes Avenue, Pittsburgh, PA 15260, USA.
Authors’ contributions
ZJ and RK performed most of the experiments and helped in the
preparation of the manuscript. SJ helped in site-directed mutagenesis and
flow cytometry. TKP helped through reagents, discussions and editing of the
manuscript. RB conceived the study, participated in its design and
coordination, prepared the manuscript and supervised the project. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 12 November 2010 Accepted: 22 July 2011
Published: 22 July 2011
References
1. Jackson SP, Bartek J: The DNA-damage response in human biology and
disease. Nature 2009, 461:1071-8.
2. Su TT: Cellular responses to DNA damage; Once signal, Multiple Choices.
Annual Rev Genetics 2006, 40:187-208.
3. Huen MS, Chen : The DNA damage response pathways: at the crossroad
of protein modifications. J Cell Res 2008, 18:8-16.
4. Tyteca S, Legube G, Trouche D: To die or not to die: a HAT trick. Mol Cell
2006, 24:807-8.
5. Carrozza MJ, Utley RT, Workman JL, Côté J: The diverse functions of
histoneacetyltransferase complexes. Trends Genet 2003, 19:321-9.
6. Rea S, Xouri G, Akhtar A: Males absent on the first (MOF): from flies to
humans. Oncogene 2007, 26:5385-94.
7. Iyer NG, Chin SF, Ozdag H, Daigo Y, Hu DE, Cariati M, Brindle K, Aparicio S,
Caldas C: p300 regulates p53-dependent apoptosis after DNA damage in
colorectal cancer cells by modulation of PUMA/p21 levels. Proc Natl Acad
Sci USA 2004, 101:7386-91.
8. Cohen HY, Lavu S, Bitterman KJ, Hekking B, Imahiyerobo TA, Miller C, Frye R,
Ploegh H, Kessler BM, Sinclair DA: Acetylation of the C terminus of Ku70
by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell 2004,
13:627-38.
9. Squatrito M, Gorrini C, Amati B: Tip60 in DNA damage response and
growth control: many tricks in one HAT. Trends Cell Biol 2006, 16:433-42.
10. Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS,
McMahon SB: Acetylation of the p53 DNA-binding domain regulates
apoptosis induction. Mol Cell 2006, 24:841-51.
11. Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W: Acetylation of p53
augments its site-specific DNA binding both in vitro and in vivo. Proc
Natl Acad Sci USA 2004, 101:2259-64.
12. Feng L, Lin T, Uranishi H, Gu W, Xu Y: Functional analysis of the roles of
Post-translational modifications at the p53 C-terminus in regulating p53
stability and activity. Mol Cell Biol 2005, 25:5389-95.
13. Cohen HY, Lavu S, Bitterman KJ, Hekking B, Imahiyerobo TA, Miller C, Frye R,
Ploegh H, Kessler BM, Sinclair DA: Acetylation of the C-terminus of Ku70
by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell 2004,
13:627-38.
14. Ianari A, Gallo R, Palma M, Aless E, Guilno A: Specific role for p300/CREB
binding protein-associated factor activity in E2F-1 stabilization in
response to DNA damage. J Biol Chem 2004, 279:30830-5.
15. Costanzo A, Merlo P, Pediconi N, Fulco M, Sartorelli V, Cole PA,
Fontemaggi G, Fanciulli M, Schiltz L, Blandino G, Balsano C, Levrero M: DNA
damage-dependent acetylation of p73α dictates the selective activation
of apoptotic target genes. Mol Cell 2002, 9:175-86.
16. Waby JS, Chirakkal H, Yu C, Griffiths GJ, Benson RS, Bingle CD, Corfe BM:
Sp1acetylation is associated with loss of DNA binding at promoters
associated with cell cycle arrest and cell death in a colon cell line. Mol
Can 2010, 9:275.
17. Sun Y, Jiang X, Chen S, Fernandes N, Price BD: A role for the Tip60 histone
acetyltransferase in the acetylation and activation of ATM. Proc Natl Acad
Sci USA 2005, 102:13182-7.
18. Gupta A, Sharma GG, Young CS, Agarwal M, Smith ER, Paull TT, Lucchesi JC,
Khanna KK, Ludwig T, Pandita TK: Involvement of human MOF in ATM
function. Mol Cell Biol 2005, 25:5292-305.
19. Gonfloni S: DNA damage stress response in germ cells: role of c-Abl and
clinical implications. Oncogene 2010, 29:6193-202.
20. Shaul Y, Ben-Yehoyada M: Role of c-Abl in the DNA damage stress
response. Cell Res 2008, 15:33-5.
21. Wang JY: Regulation of cell death by the Abl tyrosine kinase. Oncogene
2000, 19:5643-50.
22. Kharbanda S, Yuan ZM, Weichselbaum R, Kufe D: Determination of cell
fate by c-Abl activation in the response to DNA damage. Oncogene 1998,
17:3309-18.
23. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC: Neonatal
lethality and lymphopenia in mice with a homozygous disruption of the
c-abl proto-oncogene. Cell 1991, 65:1153-1163.
24. Schwartzberg PL, Stall AM, Hardin JD, Bowdish KS, Humaran T, Boast S,
Harbison ML, Robertson EJ, Goff SP: Mice homozygous for the ablm1
mutation show poor viability and depletion of selected B and T cell
populations. Cell 1991, 65:1165-1175.
25. Taagepera S, McDonald D, Loeb JE, Whitaker LL, McElroy AK, Wang JY,
Hope TJ: Nuclear-cytoplasmic shuttling of c-Abl tyrosine kinase. Proc Natl
Acad Sci USA 1998, 95:7457-62.
26. Kipreos ET, Wang JY: Cell cycle-regulated binding of c-Abl tyrosine kinase
to DNA. Science 1992, 256:382-5.
27. Miao YJ, Wang JY: Binding of A/T-rich DNA by three high mobility group-
like domains in c-Abl tyrosine kinase. J Biol Chem 1996, 271:22823-30.
28. Baskaran R, Chiang GG, Wang JY: Identification of a binding site in c-Abl
tyrosine kinase for the C-terminal repeated domain of RNA polymerase
II. Mol Cell Biol 1996, 16:3361-9.
29. Baskaran R, Wood LD, Whitaker LL, Morgan SE, Baltimore D, Wang YJ:
Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in
response to ionizing radiation. Nature 1997, 387:516-519.
30. Nie Y, Li HH, Bula CM, Liu X: Stimulation of p53 DNA binding by c-Abl
requires the p53 C terminus and tetramerization. Mol Cell Biol 2000,
20:741-8.
31. Zuckerman V, Lenos K, Popowicz GM, Silberman I, Grossman T, Marine JC,
Holak TA, Jochemsen AG, Haupt Y: c-Abl phosphorylates Hdmx and
regulates its interaction with p53. J Biol Chem 2009, 284:4031-9.
32. Tsai KK, Yuan ZM: c-Abl stabilizes p73 by a phosphorylation-augmented
interaction. Cancer Res 2003, 63:3418-24.
33. Leong CO, Vidnovic N, DeYoung MP, Sgroi D, Ellisen LW: The p63/p73
network Mediates chemosensitivity to cisplatin in a biologically defined
subset of primary breast cancers. J Clin Invest 117:1370-80.
34. Shangary S, Brown KD, Adamson AW, Edmonson S, Ng B, Pandita TK,
Yalowich J, Taccioli GE, Baskaran R: Regulation of DNA-dependent protein
kinase activity by ionizing radiation-activated abl kinase is an ATM-
dependent process. J Biol Chem 2000, 275:30163-8.
35. Yuan ZM, Huang Y, Ishiko T, Nakada S, Utsugisawa T, Kharbanda S, Wang R,
Sung P, Shinohara A, Weichselbaum R, Kufe D: Regulation of Rad51
function by c- Abl in response to DNA damage. J Biol Chem 1998,
273:3799-802.
36. Yoshida K, Komatsu K, Wang HG, Kufe D: c-Abl tyrosine kinase regulates
the human Rad9 checkpoint protein in response to DNA damage. Mol
Cell Biol 2002, 22:3292-300.
37. Kitao H, Yuan ZM: Regulation of ionizing radiation-induced Rad52
nuclear foci formation by c-Abl-mediated phosphorylation. J Biol Chem
2002, 277:48944-8.
38. David-Cordonnier MH, Hamdane M, Bailly C, D’Halluin JC: The DNA binding
domain of the human c-Abl tyrosine kinase preferentially binds to DNA
Jiang et al. Molecular Cancer 2011, 10:88
http://www.molecular-cancer.com/content/10/1/88
Page 14 of 15
sequences containing an AAC motif and to distorted DNA structures.
Biochemistry 1998, 37:6065-6076.
39. Reeves R, Nissen MS: The A/T-DNA-binding domain of mammalian high
mobility group I chromosomal proteins: A novel peptide motif for
recognizing DNA structure. J Biol Chem 1990, 265:8573-8582.
40. Chen B, Young J, Leng F: DNA bending by the mammalian high-mobility
group protein AT hook 2. Biochemistry 2010, 49:1590-5.
41. Stros M: HMGB proteins: interactions with DNA and chromatin. Biochim
Biophys Acta 2010, 1799:101-13.
42. Li AY, Boo LM, Wang SY, Lin HH, Wang CC, Yen Y, Chen BP, Chen DJ,
Ann DK: Suppression of non homologous end joining repair by
overexpression of HMGA2. Cancer Res 2009, 69:5699-706.
43. Yoshida K, Yamaguchi T, Natsume T, Kufe D, Miki Y: JNK phosphorylation
of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic
response to DNA damage. Nat Cell Biol 2005, 7:278-85.
44. Kamath R, Jiang Z, Sun G, Yalowich JC, Baskaran R: c-Abl kinase regulates
curcumin-induced cell death through activation of c-Jun N-terminal
kinase. Mol Pharmacol 2007, 71:61-72.
45. Yuan ZM, Huang Y, Whang Y, Sawyers C, Weichselbaum R, Kharbanda S,
Kufe D: Role for c-Abl tyrosine kinase in growth arrest response to DNA
damage. Nature 1996, 382:272-4.
46. Srinivasan D, Sims JT, Plattner R: Aggressive breast cancer cells are
dependent on activated Abl kinases for proliferation, anchorage-
independent growth and survival. Oncogene 2008, 27:1095-105.
47. Shiota M, Yokomizo A, Masubuchi D, Tada Y, Inokuchi J, Eto M, Uchiumi T,
Fujimoto N, Naito S: Tip60 promotes prostate cancer cell proliferation by
translocation of androgen receptor into the nucleus. Prostate 2010,
70:540-54.
48. Méndez J, Stillman B: Chromatin association of human origin recognition
complex, cdc6, and minichromosome maintenance proteins during the
cell cycle: assembly of pre-replication complexes in late mitosis. Mol Cell
Biol 2000, 20:8602-12.
doi:10.1186/1476-4598-10-88
Cite this article as: Jiang et al.: Tip60-mediated acetylation activates
transcription independent apoptotic activity of Abl. Molecular Cancer
2011 10:88.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Jiang et al. Molecular Cancer 2011, 10:88
http://www.molecular-cancer.com/content/10/1/88
Page 15 of 15
